ArticleJournal of magnetic resonance imaging : JMRI2025
MRI Assessment of Lung Water Density in Individuals Previously Infected With COVID-19: A Cross-Sectional Study.
Article in Journal of magnetic resonance imaging : JMRI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MRI Assessment of Lung Water Density in Individuals Previously Infected With COVID-19: A Cross-Sectional Study.Journal of magnetic resonance imaging : JMRI · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundLung damage in post-acute COVID-19 is a common clinical finding. Lung water density (LWD) imaging using ultrashort echo time (UTE) MRI with proton-density weighting is sensitive to edema and fibrosis. PURPOSE: To characterize LWD in COVID-19 survivors, compared with a healthy cohort. STUDY TYPE: Retrospective cohort. POPULATIONS: 185 COVID-19 survivors (63 male; age [median (interquartile range, IQR)]: 51 (25-83) years; 160 (66-363) days from COVID-19 infection to MRI) and 109 healthy controls (64 male; age: 52 (27-76) years) with no history of COVID-19 infection. FIELD STRENGTH/SEQUENCE: 2.89T; Yarnball UTE pulse sequence. ASSESSMENT: Free-breathing three-dimensional LWD images were acquired in both cohorts. Clinical demographics (age, sex, body mass index [BMI]), presence of comorbidities (hypertension, dyslipidemia, diabetes, obesity), COVID-19 hospitalization, pulmonary function, six-minute walking distance, and plasma biomarkers were recorded. STATISTICAL TESTS: Student's t-tests or Mann-Whitney U tests were used to compare lung water metrics between cohorts. The effect of comorbidities was assessed using Kruskal-Wallis tests followed by pairwise Wilcoxon tests with Bonferroni correction. Categorical variables were compared using chi-squared tests. p < 0.05 was considered significant.
resultsLWD (median (IQR)), was significantly greater in the post-COVID-19 cohort than in the healthy cohort, 31.3 (6.6)% versus 27.9 (6.5)% in men and 30.3 (7.4)% versus 27.5 (4.9)% in women. 37% of men and 24% of women in the post-COVID-19 cohort had LWD above the healthy cohort 95% confidence limit. Participants with elevated LWD had significantly higher BMI (kg/m DATA
conclusionMRI-derived LWD is elevated in COVID-19 survivors and is related to high BMI, COVID-19 hospitalization, inflammatory plasma biomarkers, and the presence of comorbidities. EVIDENCE LEVEL: 2. TECHNICAL EFFICACY: Stage 3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.